Skip to content
Open access

Revealing pan-cancer clonal niches of T cells from single-cell RNA sequencing using contrastive learning

Oct 2026 · bioRxiv · 0 citations
Biology

TL;DR

CloneTrast enables scalable and interpretable inference of clonal organization from single-cell transcriptomes and uses paired scRNA/TCR-seq during training to learn clonal-functional states from gene expression, while requiring only scRNA-seq at inference.

Abstract

T-cell clonal organization is central to anti-tumor immunity, yet its functional characterization typically requires paired single-cell RNA and TCR sequencing (scRNA/TCR-seq). Existing multimodal methods integrate transcriptome and TCR information but are limited when TCR data are unavailable. Here we present CloneTrast, a supervised contrastive-learning framework that uses paired scRNA/TCR-seq during training to learn clonal-functional states from gene expression, while requiring only scRNA-seq at inference. Using paired scRNA/TCR-seq profiles from 2.6 million human T cells across 16 cancer types, CloneTrast identified distinct T-cell clonal niches not explained solely by TCR sequence similarity or conventional cell-state annotations. Among these, an NK-like T-cell niche enriched for tumor-blood shared TCRs was consistently associated with poor immunotherapy response at the pan-cancer level. Analysis of antigen-specific T-cell clones revealed that tumor-resident and blood-borne antigen-specific T cells were preferentially associated with distinct clonal niches. Overall, CloneTrast enables scalable and interpretable inference of clonal organization from single-cell transcriptomes.

Read PDF

Similar papers

Open access Sep 2026

Tumor-versus-non-tumor T cell enrichment supported by single-cell and spatial phenotyping enables antigen-agnostic prioritization of candidate tumor-reactive TCRs

Introduction Tumor-reactive T cell receptors (TCRs) are promising candidates for the manufacturing of safe and effective adoptive TCR-T cell therapies, but their efficient identification remains a major challenge. We previously established an antigen-agnostic TCR-repertoire analysis workflow that prioritizes candidate...

V. Seitz, J. Franzen, K. Gennermann et al. · 0 citations
Open access Sep 2026

HLA-II Expression Marks Activated and Clonally Expanded CD8+ T Cells and Improves Tumor-Reactivity Prediction Across Human Cancers

Tumor-infiltrating CD8+ T cells are transcriptionally heterogeneous, and robust features linking their clonal dynamics to experimentally defined tumor reactivity remain incompletely characterized. We integrated single-cell RNA sequencing (scRNA-seq) and paired T-cell receptor sequencing (scTCR-seq) data from 31 single-...

Xue Mi, Jing-Hua Zhu, Zhu Dai et al. · 0 citations
Open access Sep 2026

Integrative single cell analysis of CD8+ T-cells across early and advanced oral cancers reveals signatures of anti-tumour activity

This work establishes a generalizable framework for mapping tumour-engaged immunity without knowledge of the underlying antigen in the transcriptome by demonstrating that clonal behaviour across space and time encodes tumour reactivity in the transcriptome.

Constance H. Li, Sheng-Qu-Ah Hong, Camille Arcinas et al. · 0 citations
Review Open access Oct 2026

Recovering CDR3 sequences from RNA-seq data: a critical assessment of computational and experimental strategies

The adaptive immune response depends on T cell receptor (TCR) diversity to counter cancers, autoimmunity, and infections. This diversity is encoded within CDR3, which serves as a unique barcode for each T cell clone. Characterizing CDR3 sequences is essential for tracking clonal dynamics, identifying neoantigen-reactiv...

Mandana Amelimojarad, Melika Amelimojarad · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.